Your support funds research to help treat and find a cure for substance use disorder.

Group photo at the Spring 2023 Cure Addiction Now webinar
Cure Addiction Now icon in white

Save the Date

Fall CAN Forum

Saturday, September 7, 2024
9:30 am • Fairmont Century Plaza

Join us for a discussion with the most prominent and leading scientists at the forefront of substance use disorder (SUD) and mental health research.

Mission Statement

Cure Addiction Now (CAN) is dedicated to the understanding, treatment and ultimate cure of "drug addiction", scientifically known as substance use disorder (SUD) while simultaneously addressing the importance of mental health as an integral part of the solution.

Funding cutting edge research and its clinical translation through a collaborative program is the core focus of the foundation. In addition to creating new therapies to help stop the deadly cycle of SUD, we hope to eliminate the negative stigma of this disease and ultimately find a cure for the brain's "addiction" to drugs.

Vision Statement

CAN funds research to develop novel therapies to treat the many stages and symptoms of substance use disorder (SUD) and simultaneously address the importance of mental health as an integral part of the solution.

Detoxing (or Detoxification from addicting drugs) should be accessible and more humane. Research initiatives will study the human brain before and after onset of SUD to understand how the brain has changed and identify ways to return to a non-dependent state in which an individual can maintain sobriety. It is equally important to create educational campaigns to remove the negative stigma of "addiction". We CAN cure SUD in our lifetime.

Our collaborative program links together multidisciplinary scientific and medical expertise to advance the understanding of the causes of substance use disorder. The collaborative goals are simple: communication and teamwork - doctors working together toward a mutual goal. When this goal is reached, all will share in the victory. CAN has cultivated the brightest, most innovative and talented scientists to work as a team and share their research on a monthly basis. Our team currently represents Mount Sinai, Harvard, UCLA, Scripps, University of Washington, UC Davis, University of Kentucky, UTMB Health and Johns Hopkins.

Each study brings unique research ideas to the collaborative group. By constant communication and no duplication of research efforts, we will greatly accelerate the development of new treatments for substance use disorder.

Meet our Scientific Advisory Board and Research Scientists.


caret-down caret-up caret-left caret-right

CAN is a unique consortium that is bringing together some of the best labs in the country to work together to conquer addiction. The CAN labs, by utilizing multidisciplinary approaches in a highly coordinated manner, promise to bring new treatments for drug addiction to the clinic as quickly as possible.

Eric J. Nestler, M.D., Ph.D. Nash Family Professor of Neuroscience, Director, Friedman Brain Institute, Dean for Academic and Scientific Affairs, Icahn School of Medicine at Mount Sinai

Cure Addiction Now fills a gaping void in the battle against addiction.  By helping translate brilliant scientific insights into tomorrow's medicines, CAN will transform not only patients' lives but society's attitude towards the brain disease of addiction. CAN will change the world - I have every confidence.

Kurt Rasmussen, Ph.D. Chief Scientific Officer, CSO Delix Therapeutics